Randomized Trial of Behavioral Intervention Versus Standard Treatment (SUPRIM)

This study has been completed.
Information provided by:
Uppsala University
ClinicalTrials.gov Identifier:
First received: April 24, 2009
Last updated: NA
Last verified: April 2009
History: No changes posted
The purpose of this study is to determine the possible preventive effect of behavioural modification versus standard treatment after hospital discharge in CHD patients.

Condition Intervention
Coronary Heart Disease
Behavioral: Behavioral interventional program

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Secondary Prevention in Uppsala Primary Health Care After Myocardial Infarction, Coronary Artery CABG and PCI. Secondary Prevention After CHD (SUPRIM).

Further study details as provided by Uppsala University:

Primary Outcome Measures:
  • Admission to hospital for recurrent CHD event [ Time Frame: 8 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Quality of life measures [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Enrollment: 362
Study Start Date: May 1996
Study Completion Date: December 2008
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Behavioral intervention
Group exposed to behavioral intervention program
Behavioral: Behavioral interventional program
Cognitive behavioral therapy intervention adapted to coronary disease patients performed in 20 group sessions during one year.
Active Comparator: Standard treatment Behavioral: Behavioral interventional program
Cognitive behavioral therapy intervention adapted to coronary disease patients performed in 20 group sessions during one year.

  Show Detailed Description


Ages Eligible for Study:   up to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Discharged from hospital with CHD
  • Age 75 years or less
  • Living in hospital catchment area
  • Able to understand Swedish
  • Willing to accept randomized group

Exclusion Criteria:

  • Psychiatric disease
  • Participated in similar study previously
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00888485

Sponsors and Collaborators
Uppsala University
Principal Investigator: Kurt Svärdsudd, MD PhD Uppsala University
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Professor Kurt Svärdsudd, Section head, Uppsala University, Department of Public Health and Caring Scienses
ClinicalTrials.gov Identifier: NCT00888485     History of Changes
Other Study ID Numbers: SMRK97  Vardal V96  FAS F0196  SOS 1471  SHLA E010 
Study First Received: April 24, 2009
Last Updated: April 24, 2009
Health Authority: Sweden: The National Board of Health and Welfare

Additional relevant MeSH terms:
Coronary Artery Disease
Coronary Disease
Myocardial Ischemia
Arterial Occlusive Diseases
Cardiovascular Diseases
Heart Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on May 26, 2016